Kevin Farmer , Ph.D.
Associate Professor and Interim Asst Dean for Tulsa Programs
Department of Pharmacy: Clinical and Administrative Sciences
Research Summary
Research Interests
Patient compliance and adherence with medications and health services, including quantitative evaluation of adherence monitoring, evaluation of interventions, and development of self-administered qualitative adherence instruments. Current research involves evaluation of adherence interventions in HIV patients receiving HAART therapy.
Use of large databases in outcomes research and pharmacoeconomic evaluations of drug therapy.
Education & Experience
Education
B.S. in Pharmacy - University of Missouri-Kansas City, 1980
Ph.D. in Pharmaceutical Sciences (Pharmacy Administration)
Thesis, "Development and Analysis of Acquisition Value Factors For U.S. Pharmaceutical Firms." 1958
Teaching Experience
Pharmacoeconomics 1 - PHAR 7704 Pharmacy Management Principles-PHAR 4702 Pharmaceutical Marketing-PHAR 5702 (elective) Clinical Communications- PHAR 4832 Graduate Course: Advanced Pharmaceutical Marketing- PHSC 6533 Special Studies in Pharmacy Administration- PHSC 5990
Selected Publications & Presentations
-
Farmer KC. Psychosocial aspects of medication adherence. In: Social and Behavioral Aspects of Pharmaceutical Care. 2nd Edition. 2009. Rickles, Wertheimer, Smith (Ed.) Jones and Bartlett Publishers.
-
Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. JAPhA 2009; 49(2): 164-170.
-
Thompson DF, Farmer KC, Beall DG, Evans DUJ, Melchert RB, Ross LA, Schmoll BJ. Identifying perceptions of professionalism in pharmacy using a four-frame leadership model. Am J Pharm Educ 2008; 72(4), Article 90.
-
Hanigan M, Dela Cruz B, Thompson D, Farmer KC, Medina P. Use of prescription and non-prescription medications and supplements by cancer patients during chemotherapy: Questionnaire validation. J Oncol Pharm Pract 2008; 14: 1-8.
-
Brahm NC, Farmer KC, Brown RC. Risperidone for the treatment of fecal smearing in a developmentally disabled adult. Am J Health-Syst Pharm 2007; 15; 64(4): 382-384.